What is Climb Bio, Inc.'s EBITDA?

Climb Bio, Inc. (CLYM) reported EBITDA of -$15.17M in Q1 2026.

How has Climb Bio, Inc.'s EBITDA changed year-over-year?

Climb Bio, Inc.'s EBITDA increased by 34.1% year-over-year, from -$23.02M to -$15.17M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Climb Bio, Inc. CLYM EBITDA

EBITDA at other companies

Vera TherapeuticsVERA

-$124.99M-119%

Kyverna Therapeutics, Inc.KYTX

-$41.02M+12.6%

Cullinan Therapeutics, Inc.CGEM

-$53.62M+2.4%

Jade Biosciences, Inc. Common StockJBIO

-$43.44M-85.8%

Bristol-Myers SquibbBMY

——

AmgenAMGN

——

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

CapEx$109.0K—

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Calculated from Climb Bio, Inc.’s reported figures.

−$15.2Mebit+

$38.0KDepreciation Depletion & Amortization

=-$15.17M

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s EBITDA?: Climb Bio, Inc. (CLYM) reported EBITDA of -$15.17M in Q1 2026.
How has Climb Bio, Inc.'s EBITDA changed year-over-year?: Climb Bio, Inc.'s EBITDA increased by 34.1% year-over-year, from -$23.02M to -$15.17M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.